MedTrace Pharma A/S — Credit Rating and Financial Key Figures

MedTrace Pharma A/S (CVR number: 36497661K) is a company from RUDERSDAL. The company reported a net sales of 2.3 mDKK in 2024, demonstrating a decline of -11.8 % compared to the previous year. The operating profit percentage was poor at -1007.4 % (EBIT: -23.5 mDKK), while net earnings were -15.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -6.5 %, which can be considered poor and Return on Equity (ROE) was -5.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 93.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. MedTrace Pharma A/S's liquidity measured by quick ratio was 3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.